FDA authorizes low-nicotine cigarettes by 22nd Century Group for public sale [CNBC]
22nd Century Group, Inc (XXII)
NASDAQ:AMEX Investor Relations:
xxiicentury.com
Company Research
Source: CNBC
The Food and Drug Administration The agency cleared applications from 22nd Century Group for its Moonlight and Moonlight Menthol cigarettes. Both products contain less nicotine than their peers, which the hopes will help reduce the number of people addicted to nicotine. Still, the cigarettes present similar health risks as conventional cigarettes, the said in a press release "Today's authorization represents the first product to successfully demonstrate the potential for these types of tobacco products to help reduce nicotine dependence among addicted smokers," Mitch Zeller, director of the 's Center for Tobacco ducts, said in a statement. "Still, we must remain vigilant to ensure that the products authorized today actually deliver on that promise for consumers." Nicotine is incredibly addictive. The in July 2017 appear to have stalled filed its application Shares of 22nd Century surged more than 30% to $1.08 a share on Tuesday. The company's stock has dropped 58% this year. Correc
Show less
Read more
Impact Snapshot
Event Time:
XXII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XXII alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XXII alerts
High impacting 22nd Century Group, Inc news events
Weekly update
A roundup of the hottest topics
XXII
News
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- 22nd Century Group Inc (XXII) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]Yahoo! Finance
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
XXII
Earnings
- 5/15/24 - Beat
XXII
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form 8-K
- 11/12/24 - Form 10-Q
- XXII's page on the SEC website